Glenmede Trust’s BioXcel Therapeutics BTAI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2020
Q4
Sell
-152
Closed -$105K 1348
2020
Q3
$105K Buy
152
+39
+35% +$26.9K ﹤0.01% 1155
2020
Q2
$95K Buy
+113
New +$95K ﹤0.01% 1166